Developing an Omni-Channel Deployment Strategy for COVID-19 Oral Antivirals

Ensuring rapid and equitable access to effective oral COVID-19 therapies is essential to reducing health disparities from COVID-19 and building a better response system for future epidemics and pandemics. A multipronged strategy for medical countermeasures must include antivirals, monoclonal antibodies, and other mechanisms to fight infections. Better strategies to deploy oral antivirals, which have been important in the context of COVID-19, will also help to prepare the system to deploy medical countermeasures at a large scale in future outbreaks.

Related Keywords

Kenya ,United States ,India ,Nigeria ,Ghana ,Maisha Meds ,Molnupiravir Merck Lagevrio ,Malaria Initiative ,Pfizer ,Test To Treat Initiative ,Centers For Medicare ,Treatment Quick Start Consortium ,Global Fund ,Tb Partnership ,American Pharmacists Association Aph ,Health Partner Ordering Portal ,Medicaid Services ,Us Test To Treat Initiative ,Quick Start Consortium ,Treat Initiative ,Stop Test ,Partner Ordering ,Equitable Distribution Index ,Oral Antiviral Drugs ,Zip Code ,Level Social Vulnerability ,Mortality Weekly Report June ,American Pharmacists Association ,Rockethealth Uganda ,Emergency Plan ,